
1. biochemistry. 2012 jun 12;51(23):4764-71. doi: 10.1021/bi3005076. epub 2012 jun
1.

discovery biochemical characterization plasmodium thioredoxin reductase
inhibitors antimalarial set.

theobald aj(1), caballero i, coma i, colmenarejo g, cid c, gamo fj, hibbs mj,
bass al, thomas da.

author information: 
(1)glaxosmithkline, medicines research centre, stevenage, hertfordshire, uk.
andrew.j.theobald@gsk.com

plasmodium falciparum prevalent deadly species human
malaria parasites, thioredoxin reductase (trxr) enzyme involved 
redox response oxidative stress. essential p. falciparum survival, the
enzyme highlighted promising target novel antimalarial drugs.
here report discovery characterization seven molecules an
antimalarial set 13533 compounds single-target trxr biochemical
screens. produced high-purity, full-length, recombinant native enzyme
from four plasmodium species, thioredoxin substrates p. falciparum and
rattus norvegicus. enzymes screened using unique, high-throughput, 
vitro native substrate assay, observed selectivity the
plasmodium species mammalian form enzyme. indicated
differences biomolecular profiles provided valuable insights
into biochemical mechanisms action compounds proven antimalarial
activity.

doi: 10.1021/bi3005076 
pmid: 22612231  [indexed medline]

